WASHINGTON — The Senate cleared the way yesterday for the likely adoption of a measure that would legalize the reimportation of lower-cost prescription drugs from Canada and other countries, a move supporters say would save consumers $50 billion over 10 years. Ignoring a White House veto threat, lawmakers voted 63 to 28 to move to a final vote on adding the drug provision to a larger bill on the operations of the Food and Drug Administration. ‘There is a pricing problem with prescription drugs,’ said Sen. Byron L. Dorgan (D-N.D.), who co-sponsored the amendment with Sen. Olympia J. Snowe (R-Maine). ‘The identical drug, FDA-approved, the same pill, put in the same bottle, made by the same company, is set virtually every other place in the world at a lower price. And the American consumer is told, ‘You know what, we have a special deal for you: You get to pay the highest price in the world.’ ‘ Sen. Mike Enzi (R-Wyo.), one of the lead sponsors of the FDA bill, opposed the amendment, saying the FDA has enough trouble determining whether domestic drugs are safe. ‘I’m baffled that we want to take on all the hard […]